Citations (72)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Amelie Kinch, Helene Hallböök, Johan Arvidson, Kalle Sällström, Kåre Bondeson & Karlis Pauksens. (2018) Long-term outcome of Epstein–Barr virus DNAemia and PTLD with the use of preemptive rituximab following allogeneic HSCT. Leukemia & Lymphoma 59:5, pages 1172-1179.
Read now
Read now
Kinga Ligeti, Lutz P Müller, Carsten Müller-Tidow & Thomas Weber. (2017) Risk factors, diagnosis, and management of posttransplant lymphoproliferative disorder: improving patient outcomes with a multidisciplinary treatment approach. Transplant Research and Risk Management 9, pages 1-14.
Read now
Read now
Jan Styczynski. (2017) Managing post-transplant lymphoproliferative disorder. Expert Opinion on Orphan Drugs 5:1, pages 19-35.
Read now
Read now
L. Cattoir, V. Van Hende, P. De Paepe & E. Padalko. (2014) Epstein–Barr virus serology and PCR: conflicting results in an immunocompetent host. A case report and review of literature. Acta Clinica Belgica 69:4, pages 262-266.
Read now
Read now
Stephanie Ruf & Hans-Joachim Wagner. (2013) Determining EBV load: current best practice and future requirements. Expert Review of Clinical Immunology 9:2, pages 139-151.
Read now
Read now
Martin Schmidt-Hieber$suffix/text()$suffix/text(), Janine Zweigner, Lutz Uharek, Igor W. Blau & Eckhard Thiel. (2009) Central nervous system infections in immunocompromised patients – update on diagnostics and therapy. Leukemia & Lymphoma 50:1, pages 24-36.
Read now
Read now
Articles from other publishers (66)
Jutta Preiksaitis, Upton Allen, Catherine M. Bollard, Vikas R. Dharnidharka, Daniel E. Dulek, Michael Green, Olivia M. Martinez, Diana M. Metes, Marian G. Michaels, Françoise Smets, Richard E. Chinnock, Patrizia Comoli, Lara Danziger‐Isakov, Anne I. Dipchand, Carlos O. Esquivel, Judith A. Ferry, Thomas G. Gross, Robert J. Hayashi, Britta Höcker, Arnaud G. L’Huillier, Stephen D. Marks, George Vincent Mazariegos, James Squires, Steven H. Swerdlow, Ralf U. Trappe, Gary Visner, Steven A. Webber, James D. Wilkinson & Brtitta Maecker‐Kolhoff. (2023) The IPTA Nashville Consensus Conference on Post‐Transplant lymphoproliferative disorders after solid organ transplantation in children: III – Consensus guidelines for Epstein‐Barr virus load and other biomarker monitoring. Pediatric Transplantation 28:1.
Crossref
Crossref
Jan Storek & Julian Lindsay. (2023) Rituximab for posttransplant lymphoproliferative disorder – therapeutic, preemptive, or prophylactic?. Bone Marrow Transplantation 59:1, pages 6-11.
Crossref
Crossref
Apostolia Papalexandri, Eleni Gavriilaki, Anna Vardi, Nikolaos Kotsiou, Christos Demosthenous, Natassa Constantinou, Tasoula Touloumenidou, Panagiota Zerva, Fotini Kika, Michalis Iskas, Ioannis Batsis, Despina Mallouri, Evangelia Yannaki, Achilles Anagnostopoulos & Ioanna Sakellari. (2023) Pre-Emptive Use of Rituximab in Epstein–Barr Virus Reactivation: Incidence, Predictive Factors, Monitoring, and Outcomes. International Journal of Molecular Sciences 24:22, pages 16029.
Crossref
Crossref
Danny Toomey, Tuan L. Phan, Thommas Phan, Joshua A. Hill & Danielle M. Zerr. (2023) Viral Encephalitis after Hematopoietic Cell Transplantation: A Systematic Review. Transplantation and Cellular Therapy 29:10, pages 636.e1-636.e9.
Crossref
Crossref
Megan Kinzel, Amit Kalra, Rutvij A. Khanolkar, Tyler S. Williamson, Na Li, Faisal Khan, Robert Puckrin, Peter R. Duggan, Mona Shafey & Jan Storek. (2023) Rituximab Toxicity after Preemptive or Therapeutic Administration for Post-Transplant Lymphoproliferative Disorder. Transplantation and Cellular Therapy 29:1, pages 43.e1-43.e8.
Crossref
Crossref
Megan Kinzel, Michelle Dowhan, Amit Kalra, Tyler S. Williamson, Rosy Dabas, Kareem Jamani, Ahsan Chaudhry, Mona Shafey, Victor Jimenez-Zepeda, Peter Duggan, Andrew Daly, Poonam Dharmani-Khan, Faisal Khan & Jan Storek. (2022) Risk Factors for the Incidence of and the Mortality due to Post-Transplant Lymphoproliferative Disorder after Hematopoietic Cell Transplantation. Transplantation and Cellular Therapy 28:1, pages 53.e1-53.e10.
Crossref
Crossref
Pascal R. Enok Bonong, Chantal Buteau, Michel Duval, Jacques Lacroix, Louise Laporte, Marisa Tucci, Nancy Robitaille, Philip C. Spinella, Geoffrey D. E. Cuvelier, Victor Lewis, Suzanne Vercauteren, Caroline Alfieri & Helen Trottier. (2021) Risk factors for post‐transplant Epstein‐Barr virus events in pediatric recipients of hematopoietic stem cell transplants. Pediatric Transplantation 25:7.
Crossref
Crossref
Pascal Roland Enok Bonong, Monica Zahreddine, Chantal Buteau, Michel Duval, Louise Laporte, Jacques Lacroix, Caroline Alfieri & Helen Trottier. (2021) Factors Associated with Post-Transplant Active Epstein-Barr Virus Infection and Lymphoproliferative Disease in Hematopoietic Stem Cell Transplant Recipients: A Systematic Review and Meta-Analysis. Vaccines 9:3, pages 288.
Crossref
Crossref
Jutta K. Preiksaitis & Catherine Burton. 2021. Post-Transplant Lymphoproliferative Disorders. Post-Transplant Lymphoproliferative Disorders
65
107
.
Angela Chiereghin, Giulia Piccirilli, Tamara Belotti, Arcangelo Prete, Clara Bertuzzi, Dino Gibertoni, Liliana Gabrielli, Gabriele Turello, Eva Caterina Borgatti, Francesco Barbato, Mariarosaria Sessa, Mario Arpinati, Francesca Bonifazi & Tiziana Lazzarotto. (2019) Clinical utility of measuring Epstein–Barr virus-specific cell-mediated immunity after HSCT in addition to virological monitoring: results from a prospective study. Medical Microbiology and Immunology 208:6, pages 825-834.
Crossref
Crossref
Irene García‐Cadenas, Lucrecia Yáñez, Isidro Jarque, Rodrigo Martino, Jose Antonio Pérez‐Simón, David Valcárcel, Jaime Sanz, Arantxa Bermúdez, Cristina Muñoz, Cristina Calderón‐Cabrera, Estefania García, Laura Alonso, Maria Suárez‐Lledó, Marta González Vicent, Inmaculada Heras, Mª Cruz Viguria, Montserrat Batlle, Lourdes Vázquez, Javier López & Carlos Solano. (2019) Frequency, characteristics, and outcome of PTLD after allo‐SCT: A multicenter study from the Spanish group of blood and marrow transplantation (GETH). European Journal of Haematology 102:6, pages 465-471.
Crossref
Crossref
Sanjeet Singh Dadwal. (2019) Herpes Virus Infections Other than Cytomegalovirus in the Recipients of Hematopoietic Stem Cell Transplantation. Infectious Disease Clinics of North America 33:2, pages 467-484.
Crossref
Crossref
Alankrita Taneja, Joseph H. Chewning & Ayman Saad. (2019) Viral infections after allogeneic hematopoietic stem cell transplant. ADVANCES IN CELL AND GENE THERAPY 2:2, pages e43.
Crossref
Crossref
Yuhua Ru, Jia Chen & Depei Wu. (2018)
Epstein‐Barr virus post‐transplant lymphoproliferative disease (
PTLD
) after hematopoietic stem cell transplantation
. European Journal of Haematology 101:3, pages 283-290.
Crossref
Crossref
Tiziana Lazzarotto, Angela Chiereghin, Antonio Piralla, Giulia Piccirilli, Alessia Girello, Giulia Campanini, Liliana Gabrielli, Cristina Costa, Arcangelo Prete, Francesca Bonifazi, Alessandro Busca, Roberto Cairoli, Anna Amelia Colombo, Marco Zecca, Francesca Sidoti, Gabriele Bianco, Pierpaolo Paba, Carlo Federico Perno, Rossana Cavallo & Fausto Baldanti. (2018) Cytomegalovirus and Epstein-Barr Virus DNA Kinetics in Whole Blood and Plasma of Allogeneic Hematopoietic Stem Cell Transplantation Recipients. Biology of Blood and Marrow Transplantation 24:8, pages 1699-1706.
Crossref
Crossref
Seema Naik, Hong Zheng, Kevin Rakszawski, Clare Sample, Jeff Sample & Michael Bayerl. 2018. Organ Donation and Transplantation - Current Status and Future Challenges. Organ Donation and Transplantation - Current Status and Future Challenges.
Amit Kalra, Cameron Roessner, Jennifer Jupp, Tyler Williamson, Raymond Tellier, Ahsan Chaudhry, Faisal Khan, Minakshi Taparia, Victor H. Jimenez‐Zepeda, Douglas A. Stewart, Andrew Daly & Jan Storek. (2017) Risk factors for post‐transplant lymphoproliferative disorder after Thymoglobulin‐conditioned hematopoietic cell transplantation. Clinical Transplantation 32:1.
Crossref
Crossref
Frederick S. Nolte. 2018. Principles and Applications of Molecular Diagnostics. Principles and Applications of Molecular Diagnostics
87
124
.
David G. Crockett, James O. Armitage & Julie M. Vose. 2018. Neoplastic Diseases of the Blood. Neoplastic Diseases of the Blood
951
973
.
Taxiarchis Botsis, Christopher Jankosky, Deepa Arya, Kory Kreimeyer, Matthew Foster, Abhishek Pandey, Wei Wang, Guangfan Zhang, Richard Forshee, Ravi Goud, David Menschik, Mark Walderhaug, Emily Jane Woo & John Scott. (2016) Decision support environment for medical product safety surveillance. Journal of Biomedical Informatics 64, pages 354-362.
Crossref
Crossref
Lesia K. Dropulic & Howard M. Lederman. 2016. Diagnostic Microbiology of the Immunocompromised Host. Diagnostic Microbiology of the Immunocompromised Host
1
50
.
Lesia K. Dropulic & Howard M. Lederman. (2016) Overview of Infections in the Immunocompromised Host. Microbiology Spectrum 4:4.
Crossref
Crossref
Ahmed Abdulkarim Ibrahim, Musa Ahmed Mohamed, Babiker Ahmed Babiker, Mohamed Bashir Musa & Hassan Hussein Musa. (2016) Serological markers of Epstein-Barr virus in renal transplant recipients. Asian Pacific Journal of Tropical Disease 6:7, pages 509-512.
Crossref
Crossref
María Dolores Fellner, Karina A. Durand, Veronica Solernou, Andrea Bosaleh, Ziomara Balbarrey, María T. García de Dávila, Marcelo Rodríguez, Lucía Irazu, Lidia V. Alonio & María A. Picconi. (2016) Epstein–Barr virus load in transplant patients: Early detection of post-transplant lymphoproliferative disorders. Revista Argentina de Microbiología 48:2, pages 110-118.
Crossref
Crossref
A. Chiereghin, A. Prete, T. Belotti, D. Gibertoni, G. Piccirilli, L. Gabrielli, A. Pession & T. Lazzarotto. (2016) Prospective Epstein–Barr virus‐related post‐transplant lymphoproliferative disorder prevention program in pediatric allogeneic hematopoietic stem cell transplant: virological monitoring and first‐line treatment. Transplant Infectious Disease 18:1, pages 44-54.
Crossref
Crossref
Angela Chiereghin, Clara Bertuzzi, Giulia Piccirilli, Liliana Gabrielli, Diego Squarzoni, Gabriele Turello, Martina Ferioli, Mariarosaria Sessa, Francesca Bonifazi, Lucia Zanoni, Elena Sabattini & Tiziana Lazzarotto. (2016) Successful management of EBV-PTLD in allogeneic bone marrow transplant recipient by virological–immunological monitoring of EBV infection, prompt diagnosis and early treatment. Transplant Immunology 34, pages 60-64.
Crossref
Crossref
. 2016. Molecular Microbiology. Molecular Microbiology
476
486
.
Jutta K. Preiksaitis, Sandra M. Cockfield & Anthea C. Peters. 2016. Transplant Infections. Transplant Infections
477
512
.
Jennifer A. Kanakry & Richard F. Ambinder. 2015. Thomas’ Hematopoietic Cell Transplantation. Thomas’ Hematopoietic Cell Transplantation
1105
1113
.
Jan Styczynski & Per Ljungman. 2015. Clinical Guide to Transplantation in Lymphoma. Clinical Guide to Transplantation in Lymphoma
253
260
.
María Dolores Fellner, Karina Durand, Marcelo Rodriguez, Lucía Irazu, Virginia Alonio & María Alejandra Picconi. (2014) Duplex realtime PCR method for Epstein–Barr virus and human DNA quantification: its application for post-transplant lymphoproliferative disorders detection. The Brazilian Journal of Infectious Diseases 18:3, pages 271-280.
Crossref
Crossref
Ren Lin & Qifa Liu. (2013) Diagnosis and treatment of viral diseases in recipients of allogeneic hematopoietic stem cell transplantation. Journal of Hematology & Oncology 6:1.
Crossref
Crossref
W J F M van der Velden, T Mori, W B C Stevens, A F J de Haan, F F Stelma, N M A Blijlevens & J P Donnelly. (2013) Reduced PTLD-related mortality in patients experiencing EBV infection following allo-SCT after the introduction of a protocol incorporating pre-emptive rituximab. Bone Marrow Transplantation 48:11, pages 1465-1471.
Crossref
Crossref
Li Xuan, Xinmiao Jiang, Jing Sun, Yu Zhang, Fen Huang, Zhiping Fan, Xutao Guo, Min Dai, Can Liu, Guopan Yu, Xian Zhang, Meiqing Wu, Xiaojun Huang & Qifa Liu. (2013) Spectrum of Epstein-Barr Virus–Associated Diseases in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation. Transplantation 96:6, pages 560-566.
Crossref
Crossref
Q.‐F. Liu, Y.‐W. Ling, Z.‐P. Fan, Q.‐L. Jiang, J. Sun, X.‐L. Wu, J. Zhao, Q. Wei, Y. Zhang, G.‐P. Yu, M.‐Q. Wu & R. Feng. (2013)
E
pstein–
B
arr virus (
EBV
) load in cerebrospinal fluid and peripheral blood of patients with
EBV
‐associated central nervous system diseases after allogeneic hematopoietic stem cell transplantation
. Transplant Infectious Disease 15:4, pages 379-392.
Crossref
Crossref
Qifa Liu, Li Xuan, Hui Liu, Fen Huang, Hongsheng Zhou, Zhiping Fan, Ke Zhao, Meiqing Wu, Lanping Xu, Xiao Zhai, Fuhua Zhang, Can Liu, Jing Sun & Xiaojun Huang. (2013) Molecular monitoring and stepwise preemptive therapy for Epstein–Barr virus viremia after allogeneic stem cell transplantation. American Journal of Hematology 88:7, pages 550-555.
Crossref
Crossref
Edward A. FaberJr.Jr., Julie M. Vose, James O. Armitage & Philip J. Bierman. 2013. Neoplastic Diseases of the Blood. Neoplastic Diseases of the Blood
1027
1047
.
Xiu-li Wu & Qi-fa Liu. (2012) Epstein - Barr virus - associated Diseases in Allogeneic Hematopoietic Stem Cell Transplantation. Journal of Hematology & Oncology 5:S1.
Crossref
Crossref
Li Xuan, Fen Huang, Zhiping Fan, Hongsheng Zhou, Xian Zhang, Guopan Yu, Yu Zhang, Can Liu, Jing Sun & Qifa Liu. (2012) Effects of intensified conditioning on Epstein-Barr virus and cytomegalovirus infections in allogeneic hematopoietic stem cell transplantation for hematological malignancies. Journal of Hematology & Oncology 5:1.
Crossref
Crossref
Carol J. Holman, Amy B. Karger, Beth D. Mullan, Richard C. Brundage & Henry H. BalfourJrJr. (2012) Quantitative Epstein–Barr virus shedding and its correlation with the risk of post‐transplant lymphoproliferative disorder. Clinical Transplantation 26:5, pages 741-747.
Crossref
Crossref
S. Ruf, K. Behnke-Hall, B. Gruhn, J. Bauer, M. Horn, J. Beck, A. Reiter & H.J. Wagner. (2012) Comparison of six different specimen types for Epstein-Barr viral load quantification in peripheral blood of pediatric patients after heart transplantation or after allogeneic hematopoietic stem cell transplantation. Journal of Clinical Virology 53:3, pages 186-194.
Crossref
Crossref
Jovana Cukuranovic, Sladjana Ugrenovic, Ivan Jovanovic, Milan Visnjic & Vladisav Stefanovic. (2012) Viral Infection in Renal Transplant Recipients. The Scientific World Journal 2012, pages 1-18.
Crossref
Crossref
Steven A. Pergam, Debra K. Mattson & Michael Boeckh. 2012. Leukemia and Related Disorders. Leukemia and Related Disorders
309
365
.
George M. Viola, Youli Zu, Kelty R. Baker & Saima Aslam. (2010) Epstein–Barr virus-related lymphoproliferative disorder induced by equine anti-thymocyte globulin therapy. Medical Oncology 28:4, pages 1604-1608.
Crossref
Crossref
Robin Patel & Frederick S. Nolte. 2011. Molecular Microbiology. Molecular Microbiology
631
640
.
C Cutler, K Stevenson, H T Kim, J Brown, S McDonough, M Herrera, C Reynolds, D Liney, G Kao, V Ho, P Armand, J Koreth, E Alyea, B R Dey, E Attar, T Spitzer, V A Boussiotis, J Ritz, R Soiffer, J H Antin & K Ballen. (2010) Double umbilical cord blood transplantation with reduced intensity conditioning and sirolimus-based GVHD prophylaxis. Bone Marrow Transplantation 46:5, pages 659-667.
Crossref
Crossref
Nishitha Reddy, Katayoun Rezvani, A. John Barrett & Bipin N. Savani. (2011) Strategies to Prevent EBV Reactivation and Posttransplant Lymphoproliferative Disorders (PTLD) after Allogeneic Stem Cell Transplantation in High-Risk Patients. Biology of Blood and Marrow Transplantation 17:5, pages 591-597.
Crossref
Crossref
Luciana Cristina Fagundes Gequelin, Irina N Riediger, Sueli M Nakatani, Alexander W Biondo & Carmem M Bonfim. (2011) Epstein-Barr virus. Revista Brasileira de Hematologia e Hemoterapia 33:5, pages 383-388.
Crossref
Crossref
Georg Maschmeyer & Per Ljungman. 2011. Principles and Practice of Cancer Infectious Diseases. Principles and Practice of Cancer Infectious Diseases
17
25
.
M Faraci, I Caviglia, G Morreale, E Lanino, D Cuzzubbo, S Giardino, E Di Marco, C Cirillo, F Scuderi, S Dallorso, P Terranova, C Moroni & E Castagnola. (2009) Viral-load and B-lymphocyte monitoring of EBV reactivation after allogeneic hemopoietic SCT in children. Bone Marrow Transplantation 45:6, pages 1052-1055.
Crossref
Crossref
Barbara Gärtner & Jutta K. Preiksaitis. (2010) EBV viral load detection in clinical virology. Journal of Clinical Virology 48:2, pages 82-90.
Crossref
Crossref
Per Ljungman. (2010) Molecular monitoring of viral infections after hematopoietic stem cell transplantation. International Journal of Hematology 91:4, pages 596-601.
Crossref
Crossref
Margaret L. Gulley & Weihua Tang. (2010) Using Epstein-Barr Viral Load Assays To Diagnose, Monitor, and Prevent Posttransplant Lymphoproliferative Disorder. Clinical Microbiology Reviews 23:2, pages 350-366.
Crossref
Crossref
Jutta K. Preiksaitis. 2010. Post-Transplant Lymphoproliferative Disorders. Post-Transplant Lymphoproliferative Disorders
45
67
.
Ran Reshef, Alicia K. Morgans & Donald E. Tsai. 2010. Allogeneic Stem Cell Transplantation. Allogeneic Stem Cell Transplantation
597
618
.
Per Ljungman. 2010. Allogeneic Stem Cell Transplantation. Allogeneic Stem Cell Transplantation
505
532
.
Margaret L. Gulley. 2010. Molecular Pathology of Hematolymphoid Diseases. Molecular Pathology of Hematolymphoid Diseases
359
365
.
J. Styczynski, H. Einsele, L. Gil & P. Ljungman. (2009) Outcome of treatment of Epstein–Barr virus‐related post‐transplant lymphoproliferative disorder in hematopoietic stem cell recipients: a comprehensive review of reported cases. Transplant Infectious Disease 11:5, pages 383-392.
Crossref
Crossref
H. Omar, H. Hägglund, Å. Gustafsson‐Jernberg, K. LeBlanc, J. Mattsson, M. Remberger, O. Ringdén, E. Sparrelid, M. Sundin, J. Winiarski, Z. Yun & P. Ljungman. (2009) Targeted monitoring of patients at high risk of post‐transplant lymphoproliferative disease by quantitative Epstein–Barr virus polymerase chain reaction. Transplant Infectious Disease 11:5, pages 393-399.
Crossref
Crossref
John W. Hiemenz. (2009) Management of Infections Complicating Allogeneic Hematopoietic Stem Cell Transplantation. Seminars in Hematology 46:3, pages 289-312.
Crossref
Crossref
Ola LandgrenEthel S. Gilbert, J. Douglas RizzoGérard SociéPeter M. BanksKathleen A. SobocinskiMary M. HorowitzElaine S. JaffeDouglas W. KingmaLois B. Travis, Mary E. Flowers, Paul J. Martin, H. Joachim Deeg & Rochelle E. Curtis. (2009) Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation. Blood 113:20, pages 4992-5001.
Crossref
Crossref
H C E Buyck, S Ball, P Junagade, J Marsh & S Chakrabarti. (2008) Prior immunosuppressive therapy with antithymocyte globulin increases the risk of EBV-related lymphoproliferative disorder following allo-SCT for acquired aplastic anaemia. Bone Marrow Transplantation 43:10, pages 813-816.
Crossref
Crossref
J Styczynski, P Reusser, H Einsele, R de la Camara, C Cordonnier, K N Ward, P Ljungman & D Engelhard. (2008) Management of HSV, VZV and EBV infections in patients with hematological malignancies and after SCT: guidelines from the Second European Conference on Infections in Leukemia. Bone Marrow Transplantation 43:10, pages 757-770.
Crossref
Crossref
Lesia K. Dropulic & Howard M. Lederman. 2008. Diagnostic Microbiology of the Immunocompromised Host. Diagnostic Microbiology of the Immunocompromised Host
1
43
.
S Ocheni, N Kroeger, T Zabelina, I Sobottka, F Ayuk, C Wolschke, A Muth, H Lellek, L Petersen, R Erttmann, H Kabisch, A R Zander & U Bacher. (2008) EBV reactivation and post transplant lymphoproliferative disorders following allogeneic SCT. Bone Marrow Transplantation 42:3, pages 181-186.
Crossref
Crossref
Margaret L. Gulley & Weihua Tang. (2008) Laboratory Assays for Epstein-Barr Virus-Related Disease. The Journal of Molecular Diagnostics 10:4, pages 279-292.
Crossref
Crossref